Suzhou, China · Founded 2021 · Privately Held (backing)
Developer of stem cell treatment solutions intended to improve major disease treatment and drug discovery. Xellsmart is based in Suzhou, China and was founded in 2021. Its last reported valuation was $158 million in Mar 2023. It has raised $156 million.
Last reported valuation
$158.0M
Oct 2026
Priced at
—
Total raised
$156.1M
Last round
—
Cap table — not yet on record
Xellsmart's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Xellsmart with a free account
·The complete investor list: 34 names
·Watch Xellsmart: the Monday email on marks, rounds and moves
